This Article Full Text Full Text (PDF) eLetters: Submit a response to this article Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services E-mail this article link to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ferry, J. A. Search for Related Content PubMed PubMed Citation Articles by Ferry, J. A.

Lymphoma Series: Variants of Large-Cell Lymphoma

Burkitt’s Lymphoma: Clinicopathologic Features and Differential Diagnosis

James Homer Wright Pathology Laboratories of the Massachusetts General Hospital and the Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA

Key Words. Burkitt’s lymphoma • Immunophenotype • c-myc • Outcome • Differential diagnosis

Correspondence: Judith A. Ferry, M.D., Department of Pathology, Massachusetts General Hospital, 55 Fruit Street, Boston, Massachusetts 02114, USA. Telephone: 617-726-3978; Fax: 617-726-7474; e-mail: jferry{at}partners.org

Burkitt’s lymphoma is a highly aggressive lymphoma identified and described in the last century by Denis Burkitt in Africa, in areas endemic for malaria. Since its description in African children, it has been recognized outside areas with endemic malaria, frequently also in children as well as among individuals with an underlying immunodeficiency. Since its initial designation as Burkitt’s lymphoma, this type of lymphoma and lymphomas closely resembling it have received a variety of names in different classifications of lymphomas and leukemias: undifferentiated lymphoma, Burkitt’s and non-Burkitt’s type in the modified Rappaport Classification, malignant lymphoma, small non-cleaved cell, Burkitt’s type in the Working Formulation, Burkitt’s lymphoma and high-grade B-cell lymphoma, Burkitt-like in the REAL Classification, and acute lymphoblastic leukemia, L3 type in the FAB Classification. With the publication of the WHO Classification of Haematopoietic and Lymphoid Tumors, the nomenclature of this lymphoma has come full circle, and it is once again known simply as Burkitt’s lymphoma. In recent years, efforts have focused on improving therapy for this rapidly proliferating neoplasm while minimizing, to the extent possible, treatment-associated toxicity. These efforts have led to the development of high-intensity, short-duration combination chemotherapy that has proven extremely effective for a high proportion of Burkitt’s lymphoma patients. The differential diagnosis of Burkitt’s lymphoma is broad, and precise diagnosis based on histologic, immunophenotypic, and genetic features remains the critical first step in planning appropriate therapy.

This article has been cited by other articles:

				D. M. Biko, S. A. Anupindi, A. Hernandez, L. Kersun, and R. Bellah Childhood Burkitt Lymphoma: Abdominal and Pelvic Imaging Findings Am. J. Roentgenol., May 1, 2009; 192(5): 1304 - 1315. [Abstract] [Full Text] [PDF]

				H C Moore, K M Wood, M S Jackson, M A Lastowska, D Hall, H Imrie, C P F Redfern, P E Lovat, F Ponthan, K O'Toole, et al. Histological profile of tumours from MYCN transgenic mice J. Clin. Pathol., October 1, 2008; 61(10): 1098 - 1103. [Abstract] [Full Text] [PDF]

				G Brady, G J MacArthur, and P J Farrell Epstein-Barr virus and Burkitt lymphoma Postgrad. Med. J., July 1, 2008; 84(993): 372 - 377. [Abstract] [Full Text] [PDF]

				P. R. Bhosale, M. Patnana, C. Viswanathan, and J. Szklaruk The Inguinal Canal: Anatomy and Imaging Features of Common and Uncommon Masses RadioGraphics, May 1, 2008; 28(3): 819 - 835. [Abstract] [Full Text] [PDF]

				G Brady, G J MacArthur, and P J Farrell Epstein Barr virus and Burkitt lymphoma J. Clin. Pathol., December 1, 2007; 60(12): 1397 - 1402. [Abstract] [Full Text] [PDF]

				B. Maecker, T. Jack, M. Zimmermann, H. Abdul-Khaliq, M. Burdelski, A. Fuchs, P. Hoyer, S. Koepf, U. Kraemer, G. F. Laube, et al. CNS or Bone Marrow Involvement As Risk Factors for Poor Survival in Post-Transplantation Lymphoproliferative Disorders in Children After Solid Organ Transplantation J. Clin. Oncol., November 1, 2007; 25(31): 4902 - 4908. [Abstract] [Full Text] [PDF]